ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of an IFN-β-associated gene signature for the prediction of overall survival among glioblastoma patients

Cheng, Lijing; Yuan, Meiling; Li, Shu; Lian, Zhiying; Chen, Junjing; Lin, Weibiao; Zhang, Jianbo*; Zhong, Shupeng*南昌大学; 南方医科大学; 1
Annals of Translational Medicine2021-6DOI: 10.21037/atm-21-1986
6被引3阅读
引用收藏
分享

摘要

Background: Brain glioblastoma multiforme (GBM) is the most common primary malignant intracranial tumor. The prognosis of this disease is extremely poor. While the introduction of beta-interferon (IFN-beta) regimen in the treatment of gliomas has significantly improved the outcome of patients; The mechanism by which IFN-beta induces increased TMZ sensitivity has not been described. Therefore, the main objective of the study was to elucidate the molecular mechanisms responsible for the beneficial effect of IFN beta in GBM. @@@ Methods: Messenger RNA expression profiles and clinicopathological data were downloaded from The Cancer Genome Atlas (TCGA) GBM and GSE83300 dataset from the Gene Expression Omnibus. Univariate Cox regression analysis and lasso Cox regression model established a novel 4-gene IFN-beta signature (peroxiredoxin 1, Sec61 subunit beta, X-ray repair cross-complementing 5, and Bcl-2-like protein 2) for GBM prognosis prediction. Further, GBM samples (n=50) and normal brain tissues (n=50) were then used for real-time polymerase chain reaction experiments. Gene set enrichment analysis (GSEA) was performed to further understand the underlying molecular mechanisms. Pearson correlation was applied to calculate the correlation between the long non-coding RNAs (lncRNAs) and IFN-beta-associated genes. An lncRNA with a correlation coefficient vertical bar R-2 vertical bar >0.3 and P<0.05 was considered to be an IFN-beta-associated lncRNA. @@@ Results: Patients in the high-risk group had significantly poorer survival than patients in the low-risk group. The signature was found to be an independent prognostic factor for GBM survival. Furthermore, GSEA revealed several significantly enriched pathways, which might help explain the underlying mechanisms. Our study identified a novel robust 4-gene IFN-beta signature for GBM prognosis prediction. The signature might contain potential biomarkers for metabolic therapy and treatment response prediction for GBM patients. @@@ Conclusions: In the present study, we established a novel IFN-beta-associated gene signature to predict the overall survival of GBM patients, which may help in clinical decision making for individual treatment.

学科与关键词

关键词
The Cancer Genome Atlas (TCGA)Gene Expression Omnibus (GEO)Chinese Glioma Genome Atlas (CGGA)beta-interferon (IFN-beta)glioblastomaprognostic model
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Annals of Translational Medicine
发表日期
2021-06
卷期
第 9 卷, 第 11 期
页码
925
DOI
10.21037/atm-21-1986
期刊收录
NSL
期刊等级
3区
成果收录
SCIE

作者

  • C

    Cheng, Lijing (第一作者)

    1

  • Y

    Yuan, Meiling

    1

查看全部 8 位作者收起作者
  • L

    Li, Shu

    dalian med univ

  • L

    Lian, Zhiying

    2 · southern med univ

  • C

    Chen, Junjing

    jiangxi canc hosp · nanchang univ

  • L

    Lin, Weibiao

    2 · zhongshan city peoples hosp

  • Z

    Zhang, Jianbo (通讯)

    2 · zhongshan city peoples hosp

  • Z

    Zhong, Shupeng (通讯)

    2 · zhongshan city peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417